Aurora Health Care

Accell Clinical Research is an international full-service Contract Research Organization (CRO) managing Phase I-III clinical trials for 10+ years across Eastern Europe. With local presence, including highly qualified medical staff and legal entities in the region, we successfully recruit patients both in EU and outside EU in post-Soviet countries (CIS). All together we provide guaranteed fast patient recruitment in 20+ countries across the region.

⬇︎ ACCELL'S SERVICES for Phase I-III clinical trials:

• Strategic guidance and trial set-up:
• Feasibility research and site selection
• Study documentation development
• Regulatory support
• Clinical supply import and management
• Selection and management of clinical study vendors
• Project management
• Clinical & medical monitoring
• Data management and biostatistics
• Quality assurance
• Safety management
• TMF/eTMF services
• Functional outsourcing of a clinical team

⬇︎ THERAPEUTIC AREAS
• Oncology
• Cardiovascular
• Immunology
• Gastroenterology
• Neurology
• Endocrinology

Aepodia is specialized in the strategy and delivery of early drug and Medical Devices development and provides scientific consultancy as well as operational support across various indications including but not limited to CNS, Endocrinology, Metabolic Disease, Oncology...

Our very experienced clinical trial team can implement, manage and execute clinical trials, by offering “ad hoc” or “full services” support to complement the sponsor’s internal team (e.g., Regulatory Strategy, Study design, Project Coordination, Monitoring, Competent Authority Submission, Site Selection/Assessment/Management, Medical Writing …).

In addition to traditional services, Aepodia conducts preclinical and clinical Due Diligence to facilitate your out-licensing or in-licensing activities.

ASCOPHARM Groupe NOVASCO Group represents one of the most proactive Contract Research Organization in the field of Clinical Research in Europe.

Founded in 1995 the original company, has now been raised to a full clinical and medical service group, together with original financial services dedicated to Clinical development.

The company has now specificities and expertise in a number of aspects of clinical research. ASCOPHARM Groupe NOVASCO have raised up expertise in certain therapeutic fields : Oncology, Transplant, Immune modulators, Rheumatology, Cardiovascular disease, Ophthalmology. The Group has also developed original services for site management and support (Site CRA services).

Together will all services offered, ASCOPHARM Groupe NOVASCO has strongly developed its expertise in Information Technologies and Computer Software. Original tools have been developed (eCRF, Project Management tools, etc…) and an IT company has been integrated to the group.

ASCOPHARM Groupe NOVASCO conducts activities in France and in most European countries.

ECLA is an Academic Research Organization devoted to provide support and expertise for the conduct of clinical trials in Latin America.

With headquarters located in Rosario, Argentina, offices in Montevideo -Uruguay and local representations in Sao Paulo-Brazil, Temuco-Chile, Lima-Peru, Bucaramanga-Colombia and Quito-Ecuador, ECLA leads the coordination of clinical trials in the region.

In the early days of 1987, ECLA designed and conducted the first full-scale clinical trial in the setting of acute myocardial infarction in collaboration with Oxford University, UK. Since then, more than 30.000 patients have been enrolled in controlled clinical trials.

ECLA helps the pharmaceutical industry in its efforts to bring cutting edge therapies to the marketplace by providing a wide range of services:
- Academic leadership
- Project, site and regulatory management
- Monitoring
- Quality Assurance
- Pharmacy
- Financial and legal assistance
- Data management and statistical support

ECLA has been collaborating with worldwide academic organizations and pharmaceutical companies for the design, set up and conduct of clinical trials in the following therapeutic areas: cardiology, diabetes, epidemiology, oncology, neurology, pneumology and vaccines.

Founded in 1997, Ergomed plc is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, and Ergomed Clinical Research, a complete, global Phase I-IV clinical development and trial management services with a strong heritage in the development of drugs in rare diseases and oncology.

• 1 300+ highly qualified professionals
• Global full-service CRO
• 24+ years of experience
• Therapeutic specialization in oncology
• Strong expertise in rare disease trials
• Robust clinical safety system
• Choice of leading drug safety databases

Our key services include:
• Clinical Research Services
• Pharmacovigilance
• Medical Information
• Regulatory
• Medical Writing
• Site Management
• Study Physician Support
• Biostatistics
• Patient Study Support